Vanda Pharmaceuticals Files 8-K
Ticker: VNDA · Form: 8-K · Filed: Sep 19, 2024 · CIK: 1347178
| Field | Detail |
|---|---|
| Company | Vanda Pharmaceuticals Inc. (VNDA) |
| Form Type | 8-K |
| Filed Date | Sep 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, corporate-info
Related Tickers: VNDA
TL;DR
Vanda Pharma filed an 8-K, mostly corporate housekeeping. No major news yet.
AI Summary
Vanda Pharmaceuticals Inc. filed an 8-K on September 19, 2024, to report other events and financial statements. The filing details the company's corporate structure and its principal executive offices located at 2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037. No specific financial transactions or material events were detailed in the provided excerpt.
Why It Matters
This filing serves as a public record of Vanda Pharmaceuticals' corporate information and reporting status with the SEC.
Risk Assessment
Risk Level: low — The filing is primarily administrative and does not contain information that would immediately impact the company's risk profile.
Key Players & Entities
- Vanda Pharmaceuticals Inc. (company) — Registrant
- 2200 Pennsylvania Avenue NW Suite 300E Washington DC 20037 (location) — Principal executive offices
- September 19, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Vanda Pharmaceuticals Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of September 19, 2024.
Where are Vanda Pharmaceuticals Inc.'s principal executive offices located?
Vanda Pharmaceuticals Inc.'s principal executive offices are located at 2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is September 19, 2024.
What is Vanda Pharmaceuticals Inc.'s state of incorporation?
Vanda Pharmaceuticals Inc. is incorporated in Delaware.
What is the SEC file number for Vanda Pharmaceuticals Inc.?
The SEC file number for Vanda Pharmaceuticals Inc. is 001-34186.
Filing Stats: 458 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-09-19 08:10:32
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share VNDA The Nasdaq Global Ma
Filing Documents
- d809647d8k.htm (8-K) — 27KB
- d809647dex991.htm (EX-99.1) — 12KB
- g809647g0919163644387.jpg (GRAPHIC) — 4KB
- 0001193125-24-221784.txt ( ) — 205KB
- vnda-20240919.xsd (EX-101.SCH) — 4KB
- vnda-20240919_def.xml (EX-101.DEF) — 13KB
- vnda-20240919_lab.xml (EX-101.LAB) — 22KB
- vnda-20240919_pre.xml (EX-101.PRE) — 14KB
- d809647d8k_htm.xml (XML) — 6KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Vanda Pharmaceuticals Inc. press release dated September 19, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 19, 2024 VANDA PHARMACEUTICALS INC. By: /s/ Timothy Williams Name: Timothy Williams Title: Senior Vice President, General Counsel and Secretary